First-ever gene therapy for hearing loss gets FDA approval: 'Groundbreaking'

The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...

FDA approves first-ever gene therapy to restore hearing

Regeneron’s drug restored hearing in 11 of 12 children in a rare, inherited condition that causes deafness.
BioSpace

FDA approval of Regeneron’s hearing loss gene therapy breaks barriers

Approved Thursday via the FDA's Commissioner’s National Priority Voucher program, Otarmeni is the first gene therapy for ...

The FDA gives the green light to the first gene therapy for deafness

The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical ...